# Trade Mark Journal No.2025/029 18 July 2025

## UK00004231289 9 July 2025 (5,35,40,42)

OPTIMIZATION-BY-DESIGN

International priority date claimed: 17 March 2025 (United States of America) (99/087,625)

Class 5
  Pharmaceutical preparations, biological preparations, and gene therapy products for medical or pharmaceutical purposes, namely, gene therapies, viral vectors, DNA plasmids, and nucleic-acid delivery products for use in the treatment of genetic diseases and disorders.
Class 35
  Business collaboration services, namely, providing a national computer-based networking web site for medical researchers to collaborate across disciplines to contract for development and manufacture of gene therapy and pharmaceutical products.
Class 40
  Manufacturing services for others in the field of pharmaceuticals, biopharmaceuticals, health care products and medical products; treatment of materials, namely, pharmaceutical and chemical products and their components used in the manufacture of pharmaceuticals and biopharmaceuticals; manufacture of pharmaceuticals and biopharmaceuticals to order and/or specification of others; contract manufacturing of pharmaceuticals, cells and gene therapy reagents.
Class 42
  Product development for others relating to pharmaceuticals, biopharmaceuticals, health care products and medical products; scientific and technological consulting services in the pharmaceutical industry, and research and design relating thereto; industrial analysis in the nature of product testing and research and industrial research in the field of pharmaceuticals, biopharmaceuticals, health care products and medical products; pharmaceutical and biopharmaceutical drug development services; pharmaceutical and biopharmaceutical research and development; product development consultation; product research services, namely, providing analytical testing, biosafety testing, reporting and laboratory services for others; scientific and technical product development consulting and research services for the pharmaceutical industry; custom design and development of chemical reagents and biochemical assays; providing a computer software platform for users to access an integrated set of scientific and technical software capabilities, namely, software for enterprise resource planning, quality management, document management and sharing, learning management, laboratory information management, computerized maintenance management and data capture, built with quality and security in mind to deliver value to customers through the productization of data, adoption of advanced technologies, and focusing on collaborative total experience.

Andelyn Biosciences, Inc.

Representative: Abion UK Limited